GluR6b were detected in the same neuronal populations, in the striatum or principal cells of the hippocampus ( Figure 1A) . No labeling was detected in GluR6 −/− mice for both GluR6a and GluR6b probes.
We thus examined whether GluR6a and GluR6b could form heteromers in vivo. For this purpose, we produced a specific antibody directed against the GluR6b subunit that recognized a major protein of 115 kDa in a Western blot loaded with brain membranes from wild-type mice, but not from GluR6 −/− mice ( Figure 1B) . The antiGluR6b antibody labeled a band on membranes prepared from COS-7 cells transfected with GluR6b, but not from cells transfected with GluR6a ( Figure 1B) . Conversely, the GluR6/7 antibody, which is directed against an amino acid sequence present in GluR6a, does not recognize GluR6b in COS-7 cells ( Figure 1B evoked by fast application of glutamate (1 mM) ( Figure  2A ) was about 10-fold larger for GluR6a(Q) than for GluR6b(Q) ( Figure 2B) had time constants of 9.4 ± 0.5 ms (n = 15) for GluR6a(Q) and 10.2 ± 0.8 ms for GluR6b(Q), which were Mouse GluR6a and GluR6b (originally named GluR6-2 in mouse) differ by a stretch of 54 and 15 amino acids, not significantly different (p = 0.4). The Q to R substitution in GluR6 homomers derespectively, at the ends of their C-terminal domains. In a previous report, we showed that the splice variants creases unitary conductance of the channels, reduces calcium permeability, and transforms the rectification GluR6a and GluR6b were equally well detected at the mRNA level in large brain regions using RT-PCR (Jasproperties of these receptors from inwardly rectifying to linear or slightly outwardly rectifying (Bettler and Mulle, kolski et al., 2004). To better define the respective expression patterns of the splice variants, we performed 1995; Lerma, 2003). Indeed, the amplitudes of currents evoked at −40 mV in cells expressing GluR6a(R) or in situ mRNA localization using specific oligonucleotide primers corresponding to GluR6a and GluR6b C-terGluR6b(R) were much smaller than those for their counterparts with the Q form ( Figure 2B ), with GluR6b(R) beminal domains ( Figure 1A) . Transcripts for GluR6a and ing barely detectable ( Figure 2C ). In addition, the Q/R GluR6b (n = 3) ( Figure 3A ). We used a biotinylation assay to quantify the amount of KAR proteins expressed substitution led to an outwardly rectifying I/V curve (data not shown). If GluR6a and GluR6b coassemble at the cell surface. The biotinylated fraction of mycGluR6a represented 91% ± 8% of the total myc-GluR6a within the same receptor, coexpressing GluR6a(Q) and GluR6b(R) should lead to the expression of receptors when expressed alone in COS-7 cells, an amount which did not vary when coexpressed with GluR6b ( Figure 3B (biotinylated fraction, 53% ± 11%, n = 5) when expressed alone, the large majority of GluR6b (83% ± 7%, 2000). Coexpression of both splice variants led to much larger currents at positive potentials than in cells exn = 5) was detected in the extracellular fraction when myc-GluR6b was coexpressed with GluR6a. To exampressing either GluR6a(Q) or GluR6b(R) alone as homomers ( Figures 2C and 2D ). These currents cannot be ine the distribution of the two splice variants on the plasma membrane of COS-7 cells by immunocytoattributed to the sum of homomeric GluR6a(Q)-and GluR6b(R)-mediated currents due to the very low amchemistry ( Figure 3C ), we transfected the two splice variants fused to two different extracellular epitopes plitude of homomeric GluR6b(R) currents. These data thus indicated that both splice variants were coas-(GPF-GluR6a and myc-GluR6b). When expressed separately, both GFP-GluR6a and myc-GluR6b formed agsembled.
In these experiments, we also confirmed that GluR6a gregates at the plasma membrane, but only GFPGluR6a was concentrated at intercellular junctions, promoted the surface expression of GluR6b, a splice variant which is largely retained in the endoplasmic reconsistent with the specific interaction of GluR6a with cadherin/catenin proteins (Coussen et al., 2002) . In ticulum (ER) when expressed as a homomeric protein (Jaskolski et al., 2004). We compared cells expressing cells cotransfected with GluR6a and GluR6b, the extracellular localization of myc-GluR6b matched almost exGluR6a(Q)/GluR6a(R) and cells expressing GluR6a(Q)/ GluR6b(R). The I/V curves ( Figure 2E ) and amplitudes actly that of GFP-GluR6a, and was consequently concentrated at intercellular junctions ( Figure 3C ). In (Figure 2F ) of the evoked currents were almost identical, showing that the two splice variants coassembled cultured hippocampal neurons derived from GluR5 −/− × GluR6 −/− mice, myc-GluR6b expressed at the surface and were targeted to the plasma membrane equally as well as receptors composed of only GluR6a. of the dendritic membrane was similarly colocalized entirely with GPF-GluR6a ( Figure 3D ). Thus, when GluR6a and GluR6b are coexpressed in heterologous Consequences of the Coassembly cells or in cultured neurons, GluR6b readily coassemof GluR6a and GluR6b bles with GluR6a, positively regulating the trafficking of We examined in further detail the consequences of the GluR6b to the plasma membrane and to intercellular coassembly of GluR6a and GluR6b in regard to the trafjunctions. ficking of KARs to the plasma membrane. For this purpose, we transfected cell lines and neurons in culture with epitope-tagged GluR6 splice variants. GluR6a (or
Identification of Proteins Interacting with GluR6a
Since both GluR6a and GluR6b were expressed in the myc-GluR6a) and GluR6b (or myc-GluR6b) were cotransfected in COS-7 cells. 98% ± 1% of GluR6b coimmunosame neuronal populations and coassembled in native receptors, we hypothesized that heteromerization of precipitated with myc-GluR6a, (n = 3 experiments) and 78% ± 11% of GluR6a coimmunoprecipitated with mycGluR6a and GluR6b could extend the repertoire of cyto- 
solic proteins associated with GluR6-containing KARs

Identification of Proteins Interacting with GluR6b
No binding partner of GluR6b has yet been identified. and thus might serve to bring into close proximity proteins that are functionally connected. To get a global
Proteins that specifically interact with the GluR6b C-terminal domain were isolated by peptide affinity chromaoverview of proteins interacting with the receptor C terminus of both splice variants, we used a proteomic aptography, using a synthetic peptide encompassing the last 15 C-terminal amino acids of GluR6b as bait and proach that combined either pull-down or coimmunoprecipitation experiments, 2-D electrophoresis, and separated onto 2D gels ( Figure 5 ). Eight spots that were apparent in the gels obtained with the GluR6b C-teridentification of proteins by MALDI-TOF mass spectrometry. To identify the proteins that specifically inminal peptide ( Figure 5A ) were undetectable in the gels obtained by incubating brain extracts with beads teract with the GluR6a C terminus, we performed differential analyses of: (1) proteins that were recruited by not coupled to the peptide ( Figure 5B ). Seven spots were unambiguously identified by MALDI-TOF mass the entire GluR6a C terminus fused to GST, but not by GST alone (Figures 4A and 4B) and (2) proteins that spectrometry (Table 1) . These spots corresponded to calmodulin (spot 6), protein phosphatase 2B (both were immunoprecipitated by the anti-myc antibody from membrane extracts of transgenic mice expressing the catalyticβ and the regulatory α subunits, 7 and 11), N-ethylmaleimide-sensitive fusion protein attachment myc-GluR6a (which represents 25% of the wild-type GluR6 protein) (Coussen et al., 2002) ( Figure 4C ) or of protein γ (NSF, 8), visinin-like protein 1 or VILIP-1 (9), neurocalcin delta or VILIP-3 (10), and profilin II (12). The wild-type animals (data not shown). Fifteen spots or trains of spots were present in 2D gels of both GST identity of proteins that display specific interaction with the GluR6b C terminus in pull-down experiments was pull-down experiments with the C-terminal domain of GluR6a ( Figure 4A ) and immunoprecipitation with a myc confirmed by immunoblotting with specific antibodies ( Figure 5C ). However, interactions detected in peptide antibody from transgenic mouse brains ( Figure 4C ), but were not detected when GST alone was used as a bait pull-down experiments could be due to nonspecific interactions between the GluR6b peptide and the cyto-( Figure 4B ). Among the 15 spots, we were able to identify six different proteins from their peptide mass fingersolic proteins, since the amount of peptide is much higher than in physiological conditions. We thus perprint determined by MALDI-TOF mass spectrometry (listed in Table 1 ). These proteins are spectrin (spot 1), formed coimmunoprecipitation experiments from mouse brain to determine whether these proteins interact with Contactin chain 1 or F3-contactin (2), dynamin-1 (3), dynamitin (4), 14-3-3 γ (5), and calmodulin (6). All these native KARs. The GluR6b antibody was not used in these experiments because it recognizes a sequence proteins were specifically immunoprecipitated with the anti-myc antibody from brain extracts of mice expresscorresponding to the GluR6b C-terminal domain, likely precluding the detection of proteins that interact with ing myc-GluR6a, indicating that they interact with native GluR6a in vivo (Figures 4C and 4D) .
the same domain of the GluR6b sequence. We there- Table 1 fore used myc-GluR6a transgenic mice (Coussen et al., that the proteins identified do interact with GluR6b in vivo, and also brings further support to the finding 2002). We first verified that in these mice, native GluR6b was coimmunoprecipitated with myc-GluR6a, and vice that GluR6a and GluR6b are part of the same heteromeric receptor in vivo. versa ( Figure 5D ). Since myc-GluR6a coassembled with GluR6b, proteins interacting with GluR6b may coimmuStrikingly, several GluR6b binding partners that we have identified are known to function in a Ca 2+ -depennoprecipitate with myc-GluR6a. Consistent with this hypothesis, proteins interacting with GluR6b in our dent manner. This is the case for calmodulin, calcineurin, and the VILIP proteins. We thus checked whether in vitro binding assay were immunoprecipitated with the anti-myc antibody ( Figure 5C ). This finding confirms interactions between the GluR6b C-terminal peptide Figure 6A ). The depression lasted Since GluR6a and GluR6b interact with distinct subsets less than 10 s and was most prominent at the earliest of protein partners, we hypothesized that the binding interval tested, i.e., 2 s (63% ± 5% of control current, of protein partners separately to the two GluR6 splice n = 10) ( Figure 6C ). This depression was dependent on variants could induce a crossregulation of the GluR6 a rise in intracellular Ca 2+ , since no depression was obheteromer. We thus evaluated the importance of the served when 10 mM BAPTA was included in the recordheteromerization of GluR6a and GluR6b for native KAR ing solution (90% ± 7% of control current 2 s after function. We focused on the role of calcineurin, be-NMDA application, n = 3). Then, using the recording cause its role in the physiology of native and recombipatch pipette, we dialyzed the C-terminal GluR6b pepnant KARs has been well documented. Phosphorylatide (15 amino acids, pepR6b) to compete for proteins interacting with this subunit. In pull-down experiments, tion of recombinant GluR6a by PKA increases receptor plasma membrane targeting on the timescale of minutes. However, after more than 5 min of recording to allow for dialysis of the peptide, the depression of KAR current caused by NMDA was significantly reduced compared to the control condition with no peptide (Figures 6D and 6E ) (depression to 86% ± 5% of control, 2 s after NMDA application, n = 5, p < 0.005). To test for a nonspecific effect of pepR6b, we dialysed a scrambled peptide (see Experimental Procedures); the depression was identical to the one observed without peptide ( Figure 6C , 62% ± 5% of control after 2 s, n = 6). Since the depression was reported to be dependent on dephosphorylation of KARs by calcineurin, our data suggest that binding of calcineurin to GluR6b contributes to the regulation of native KARs following Ca namin-1, NSF, and dynamitin. 14-3-3 
